According to the World Health Organizations 2008 GLOBOCAN report, 64% of global cancer deaths - and 56% of cancer cases - were registered in countries in Africa, Asia, or Latin America. So while cancer is unquestionably a global burden, its reach in the developing world points to the need for specialized study on cancer in these countries.Cancer Epidemiology:: Low- and Middle-Income Countries and Special Populations reviews the current status of cancer epidemiologic research and training - rationale, requisite infrastructure, methodologic principles, and illustrative examples in low- and middle-income countries - in order to facilitate future advances by trained health professionals. The result is a valuable resource for both program leaders and graduate and post-graduate students pursuing careers in internationalcancer epidemiologic research.
Section 1: Multidisciplinary Perspectives; 1. Burden of Cancer in Low- and Middle-Income Countries; Maria Paula Curado, Paolo Boffetta, David Schottenfeld, Jean-Marie Dangou, Karina Braga Ribeiro; 2. Migrant Studies; Song-Yi Park and Laurence N. Kolonel; 3. Molecular Epidemiology Studies in Cancer; Kelly Hirko, Maria Iniesta Donate, Sofia Merajver; 4. Opportunities for Cancer Genetic Research; Oluwafemi Oluwole, Yonglan Zheng, Olufunmilayo Olopade; 5. Cancer Screening in Low- and Middle-Income Countries; R. Sankaranarayanan, Somanathan Thara, Youlin Qiao, Twalib Ngoma, Raul Murillo; 6. Behavioral, Social, and Cultural Aspects of Epidemiologic Studies in Low- and Middle-Income Countries and in Special Populations; Robert Chamberlain; 7. Ethical Issues in Cancer Epidemiologic Studies; Steven S. Coughlin; Section 2: Methodological Principles in Conducting International Studies; 8. Case-control Studies in Low- and Middle-Income Countries; Farin Kamangar, Kyle Esdaille, Farhad Islami; 9. Cohort Studies in Low- and Middle-Income Countries; Stephanie Melkonian, Yu Chen, Habibul Ahsan; 10. Molecular Epidemiology in LMIC; Hongbing Shen and Hongxia Ma; 11. Methodological Issues in International Multicentric Studies, Including the Role of Consortia in International Cancer Epidemiology; Farhad Islami and Paolo Boffetta; Section 3: Cancer Epidemiology Research Training in LMI Countries and Special Populations: Needs and Opportunities; 12. Cancer Epidemiology Research Training in LMI Countries and Special Populations: Needs and Opportunities; Amr Soliman; 13. Cancer Epidemiology in Schools of Public Health and Medical Schools: Culture, Infrastructure, and Curricula; Amr Soliman; 14. University Resources for Academic and Field Research Training in Cancer Epidemiology; Amr Soliman and Robert Chamberlain; 15. Non-University Training Programs in Cancer Epidemiology, Emphasizing Participation from LMI Countries; Jessica Fapeol-Badger; 16. Needs and Opportunities for Epidemiologic Training of Early-career Clinicians and Scientists Seeking to Conduct Cancer Research in LMI Countries; Amr Soliman and Robert Chamberlain; Section 4: Illustrative Examples of Collaborative Field Studies; 17. Hepatitis B Virus, Aflatoxin and Primary Liver Cancer; W. Thomas London, Timothy M. Block, Katherine A. McGlynn; 18. HPV and Cervical Cancer; Rolando Herrero; 19. Studies of Tobacco Smoking and Control; Priscilla S. Reddy, Shamagonam James, Nasheen Naidoo, Ronel Sewpaul, Ken Resnicow, and Anthony Mbewu; 20. Cancer and HIV in Less Developed Countries; Sam M. Mbulaiteye; 21. Breast Cancer Early Detection and Clinical Guidelines; David B. Thomas, Raul H. Murillo, Kardinah, and Benjamin O. Anderson; Section 5: Future Directions: Emerging Opportunities and Challenges; 22. Future Directions: Emerging Opportunities and Challenges; Amr S. Soliman, David Schottenfeld, and Paulo Boffetta;
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.